226 related articles for article (PubMed ID: 31319089)
21. Cost and Resource Use of Pemphigus and Pemphigoid Disorders Pre- and Post-Rituximab.
Heelan K; Hassan S; Bannon G; Knowles S; Walsh S; Shear NH; Mittmann N
J Cutan Med Surg; 2015; 19(3):274-82. PubMed ID: 25775641
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Autoimmune Bullous Diseases in Elderly Patients in Iran: A 10-Year Retrospective Study.
Ghiasi M; Daneshpazhooh M; Ismonov M; Chams-Davatchi C
Skinmed; 2017; 15(3):175-180. PubMed ID: 28705276
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and classification of pemphigus and bullous pemphigoid.
Kershenovich R; Hodak E; Mimouni D
Autoimmun Rev; 2014; 13(4-5):477-81. PubMed ID: 24424192
[TBL] [Abstract][Full Text] [Related]
24. Association of inflammatory skin diseases with venous thromboembolism in US adults.
Shaheen MS; Silverberg JI
Arch Dermatol Res; 2021 May; 313(4):281-289. PubMed ID: 32642810
[TBL] [Abstract][Full Text] [Related]
25. Spectrum of orocutaneous disease associations: Immune-mediated conditions.
Cizenski JD; Michel P; Watson IT; Frieder J; Wilder EG; Wright JM; Menter MA
J Am Acad Dermatol; 2017 Nov; 77(5):795-806. PubMed ID: 29029901
[TBL] [Abstract][Full Text] [Related]
26. Association of bullous pemphigoid and comorbid health conditions: a case-control study.
Lee S; Rastogi S; Hsu DY; Nardone B; Silverberg JI
Arch Dermatol Res; 2021 Jul; 313(5):327-332. PubMed ID: 32647978
[TBL] [Abstract][Full Text] [Related]
27. Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016.
Schmidt E; Spindler V; Eming R; Amagai M; Antonicelli F; Baines JF; Belheouane M; Bernard P; Borradori L; Caproni M; Di Zenzo G; Grando S; Harman K; Jonkman MF; Koga H; Ludwig RJ; Kowalczyk AP; Müller EJ; Nishie W; Pas H; Payne AS; Sadik CD; Seppänen A; Setterfield J; Shimizu H; Sinha AA; Sprecher E; Sticherling M; Ujiie H; Zillikens D; Hertl M; Waschke J
J Invest Dermatol; 2017 Jun; 137(6):1199-1203. PubMed ID: 28390814
[TBL] [Abstract][Full Text] [Related]
28. Autoimmune bullous diseases associations.
Ljubojevic S; Lipozenčić J
Clin Dermatol; 2012; 30(1):17-33. PubMed ID: 22137223
[TBL] [Abstract][Full Text] [Related]
29. Association of Psoriasis with Psychiatric Hospitalization in United States Children and Adults.
Patel KR; Lee HH; Rastogi S; Singam V; Vakharia PP; Silverberg JI
Dermatology; 2019; 235(4):276-286. PubMed ID: 31163441
[TBL] [Abstract][Full Text] [Related]
30. Comorbidities and inpatient mortality for pemphigus in the U.S.A.
Hsu DY; Brieva J; Sinha AA; Langan SM; Silverberg JI
Br J Dermatol; 2016 Jun; 174(6):1290-8. PubMed ID: 26864457
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 pandemic and autoimmune bullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation.
Kasperkiewicz M; Yale M; Strong R; Zillikens D; Woodley DT; Recke A
J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):e418-e421. PubMed ID: 33724560
[No Abstract] [Full Text] [Related]
32. IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid.
Dainichi T; Chow Z; Kabashima K
J Dermatol Sci; 2017 Dec; 88(3):265-270. PubMed ID: 28747266
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and age distribution of pemphigus and pemphigoid diseases among paediatric patients in Germany.
Hübner F; König IR; Holtsche MM; Zillikens D; Linder R; Schmidt E
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2600-2605. PubMed ID: 32289873
[TBL] [Abstract][Full Text] [Related]
34. The incidence of herpes zoster in cutaneous lupus erythematosus (CLE), dermatomyositis (DM), pemphigus vulgaris (PV), and bullous pemphigoid (BP).
Robinson ES; Payne AS; Pappas-Taffer L; Feng R; Werth VP
J Am Acad Dermatol; 2016 Jul; 75(1):42-8. PubMed ID: 27317514
[TBL] [Abstract][Full Text] [Related]
35. Clinical Relevance of Polymorphonuclear Myeloid-Derived Suppressor Cells in Autoimmune-Blistering Disorders Pemphigus Vulgaris and Bullous Pemphigoid.
Oktem A; Horzum U; Ertop P; Kundakci N; Akay BN; Yalcin B; Esendagli G
J Invest Dermatol; 2021 Mar; 141(3):672-675.e1. PubMed ID: 32791069
[No Abstract] [Full Text] [Related]
36. Oral lesions in patients with pemphigus vulgaris and bullous pemphigoid.
Budimir J; Mihić LL; Situm M; Bulat V; Persić S; Tomljanović-Veselski M
Acta Clin Croat; 2008 Mar; 47(1):13-8. PubMed ID: 18714642
[TBL] [Abstract][Full Text] [Related]
37. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
[TBL] [Abstract][Full Text] [Related]
38. Association Between Inflammatory Skin Disease and Cardiovascular and Cerebrovascular Co-Morbidities in US Adults: Analysis of Nationwide Inpatient Sample Data.
Kwa MC; Silverberg JI
Am J Clin Dermatol; 2017 Dec; 18(6):813-823. PubMed ID: 28534318
[TBL] [Abstract][Full Text] [Related]
39. Human amnion membrane as a substrate for the detection of autoantibodies in pemphigus vulgaris and bullous pemphigoid.
Sezin T; Avitan-Hersh E; Indelman M; Moscona R; Sabo E; Katz R; Pollack S; Bergman R
Isr Med Assoc J; 2014 Apr; 16(4):217-23. PubMed ID: 24834757
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
